Sikkerhedsprofilen for entecavir og lamivudin, inklusiv laboratorietest- abnormaliteter, var sammenlignelig i disse forsøg.
The safety profiles of entecavir and lamivudine, including laboratory test abnormalities, were comparable in these studies.